agios pharmaceuticals inc
Lewis Clayton Cantley Ph.D.
Co-Founder, Director, Member of Scientific Advisory Board and Member of Nominating & Corporate Governance Committee, Agios Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 87 board members in 5 different organizations across 4 different industries.|
See Board Relationships
Dr. Lewis C. Cantley, Ph.D is a Co-Founder of Agios Pharmaceuticals Inc. Dr. Cantley serves as a Professor of Cell Biology and Systems Biology at Harvard Medical School and Chief of the Division of Signal Transduction at Beth Israel Deaconess Medical Center. He serves as co-editor-in-chief for the AACRs newest journal, Cancer Discovery. He joined the Department of Biochemistry and Molecular Biology at Harvard in 1978 as its Assistant Professor. Dr. Cantley's early work ...
38 Sidney StreetPhone: 617-649-8600
Cambridge, Massachusetts 02139
Board Members Memberships*
Co-Founder, Director, Member of Scientific Advisory Board and Member of Nominating & Corporate Governance Committee
Post-Doctoral Training1975 - 1978
West Virginia Wesleyan College
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Post a JobJobs
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25